+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atopic Dermatitis Drugs Market by Drug Class, Route Of Administration, Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Atopic Dermatitis Drugs Market by Drug Class, Route Of Administration, Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Atopic Dermatitis Drugs Market by Drug Class, Route Of Administration, Mode Of Administration, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904629
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The atopic dermatitis drugs market is experiencing steady growth, shaped by innovation in treatment modalities, evolving regulatory dynamics, and increasing global prevalence. As senior decision-makers seek actionable intelligence to inform strategic planning, it is crucial to understand the latest developments, market segmentation, and competitive strategies redefining this therapeutic area.

Market Snapshot: Atopic Dermatitis Drugs Market

The Atopic Dermatitis Drugs Market grew from USD 8.56 billion in 2024 to USD 9.18 billion in 2025. It is expected to continue growing at a CAGR of 6.87%, reaching USD 12.77 billion by 2030. This expansion is driven by advances in both biologic and small-molecule therapies, changing patient demographics, and widespread adoption of patient-centric digital health solutions. Strategic investments across product innovation, supply chain resilience, and data-driven patient engagement are shaping the evolving competitive landscape for atopic dermatitis therapeutics.

Scope & Segmentation

  • Drug Class: Systemic (Biologics; Small Molecule Immunosuppressants), Topical (Calcineurin Inhibitors; Corticosteroids; PDE4 Inhibitors; Vitamin D Analogues)
  • Route of Administration: Cream; Gel; Lotion; Ointment
  • Mode of Administration: Injectable (Pre Filled Syringes; Vials); Oral
  • Distribution Channel: Hospital Pharmacies (Private; Public); Online Pharmacies (Digital Health Platforms; E Commerce Platforms); Retail Pharmacies (Chain; Independent)
  • Patient Age Group: Adult; Geriatric; Pediatric
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Players Profiled: Regeneron Pharmaceuticals, Inc.; Sanofi; Pfizer Inc.; AbbVie Inc.; Eli Lilly and Company; Johnson & Johnson; LEO Pharma A/S; Galderma S.A.; Teva Pharmaceutical Industries Ltd.; Viatris Inc.

Key Takeaways

  • Targeted biologic therapies and small-molecule immunomodulators are redefining the therapeutic toolkit and shifting treatment approaches toward increased precision and individualization.
  • Digital health platforms now play a central role in patient engagement, adherence monitoring, and real-world data collection, addressing evolving regulatory expectations for post-market evidence.
  • Manufacturers are diversifying supply chains and collaborating with new domestic and nearshore partners to ensure robust sourcing and mitigate logistic and geopolitical risk.
  • Market segmentation by administration method and patient age group allows companies to tailor portfolios, driving competitive differentiation and optimizing outcomes across diverse populations.
  • Strategic partnerships between pharmaceutical firms and digital health innovators are accelerating clinical evidence generation and optimizing commercialization pathways.
  • Increasing regulatory agility, particularly regarding accelerated review and updated guidelines for novel therapies, is enabling quicker patient access and fostering innovation.

Tariff Impact

Recent United States tariffs on pharmaceutical imports have led to higher production costs within the atopic dermatitis drugs market. Companies are responding by restructuring supply chains, establishing regional partnerships, and revising formulations to maintain cost-effectiveness. As a result, stakeholder engagement with payers and providers has intensified, placing greater emphasis on pharmacoeconomic value and robust evidence to support formulary inclusion and reimbursement.

Methodology & Data Sources

This report is based on an integrated approach combining primary interviews with dermatology experts, payers, and advocacy groups, alongside secondary analysis of regulatory filings, clinical trials, company disclosures, and peer-reviewed literature. Market estimates were validated using segmentation models and triangulation methods. Regional assessment incorporated policy reviews and macroeconomic indicators, providing comprehensive market intelligence.

Why This Report Matters

  • Enables decision-makers to confidently align pipeline investments and commercialization strategies with evolving patient and market dynamics.
  • Provides actionable insights to help stakeholders navigate regulatory changes, optimize market access, and support long-term competitive positioning.
  • Delivers a nuanced understanding of supply chain, regional, and technological considerations essential for informed strategic planning.

Conclusion

The atopic dermatitis drugs market is characterized by innovation, regulatory response, and shifting patient priorities. Armed with this report’s insights, stakeholders can recognize emerging trends and proactively shape growth strategies for sustainable market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atopic Dermatitis Drugs Market, by Drug Class
8.1. Introduction
8.2. Systemic
8.2.1. Biologics
8.2.2. Small Molecule Immunosuppressants
8.3. Topical
8.3.1. Calcineurin Inhibitors
8.3.2. Corticosteroids
8.3.3. PDE4 Inhibitors
8.3.4. Vitamin D Analogues
9. Atopic Dermatitis Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Cream
9.3. Gel
9.4. Lotion
9.5. Ointment
10. Atopic Dermatitis Drugs Market, by Mode Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Pre Filled Syringes
10.2.2. Vials
10.3. Oral
11. Atopic Dermatitis Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private Hospital Pharmacies
11.2.2. Public Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Digital Health Platforms
11.3.2. E Commerce Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Atopic Dermatitis Drugs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Atopic Dermatitis Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atopic Dermatitis Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atopic Dermatitis Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Regeneron Pharmaceuticals, Inc.
16.3.2. Sanofi
16.3.3. Pfizer Inc.
16.3.4. AbbVie Inc.
16.3.5. Eli Lilly and Company
16.3.6. Johnson & Johnson
16.3.7. LEO Pharma A/S
16.3.8. Galderma S.A.
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATOPIC DERMATITIS DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ATOPIC DERMATITIS DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ATOPIC DERMATITIS DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ATOPIC DERMATITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ATOPIC DERMATITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ATOPIC DERMATITIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 71. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 75. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 77. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 78. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 79. CANADA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 138. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 171. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 172. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 175. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. ITALY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 181. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 182. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190. SPAIN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 247. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 248. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 249. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 252. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 254. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 255. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 256. QATAR ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 258. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 259. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 267. FINLAND ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 290. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 291. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 292. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 293. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 296. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 299. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 300. EGYPT ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 302. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 303. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 304. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 310. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 311. TURKEY ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Atopic Dermatitis Drugs market report include:
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi
  • Pfizer Inc.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • LEO Pharma A/S
  • Galderma S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.77 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Atopic Dermatitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Atopic Dermatitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 120 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.